Trial intelligence / Profile preview

Mirtazapine versus venlafaxine for tension headache

IRCT20210410050915N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of mirtazapine and venlafaxine in tension-type headache (TTH) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Tension headaches. Started May 2021; status: completed.

02

Drugs

mirtazapinevenlafaxine
03

Conditions

tension-type headache (TTH)

Beyond the preview

Go deeper on IRCT20210410050915N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210410050915N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call